Bruce Bean

Bruce Palmer Bean, PhD

Robert Winthrop Professor of Neurobiology

Bruce Palmer Bean, PhD – Faculty Profile

If you prefer, you can view the visual layout directly on Canva: Open Bruce Palmer Bean – Faculty Profile on Canva (opens in a new window) .

Title: Robert Winthrop Professor of Neurobiology, Harvard Medical School.

The Aim

The Bean Lab studies the pharmacology of ion channels that govern the electrical activity of neurons. Neuronal activity is regulated by molecular gates in the cell membrane called ion channels.

The Impact

Different types of neurons express different combinations of ion channels, which is why they fire differently and serve different functions. The Bean Lab uses pharmacology to study how ion channels differentially regulate electrical activity in particular kinds of neurons, both characterizing existing ion channel–targeted drugs and developing new ones. This approach has contributed to the development of new compounds that target channels in pain‑sensing neurons without the side effects and risks associated with opioids. Ongoing projects aim to develop new drugs targeting chronic pain, epilepsy, and multiple sclerosis.

A Closer Look

Article: “This Will Have a Negative Effect on the Entire Drug‑Development Enterprise” , Harvard Medicine Magazine, July 2025. This perspective explains how Bruce Bean’s lab uses basic research on neuronal ion channels and hyperexcitability to identify new, safer drug targets for pain and epilepsy, positioning the lab as an early‑stage engine for future non‑opioid therapies.

Article: The Discovery Channel: Why do Harvard doctors remain undaunted by the demands of discovery? , Harvard Medicine Magazine, Spring 2011. This feature describes how Harvard is boosting drug discovery by supporting risky early‑stage projects and collaborations; Bruce Bean’s ion‑channel research is highlighted as an example of identifying new targets for pain and epilepsy treatments that industry can later develop into drugs.

Contact

Email: bruce_bean@hms.harvard.edu

Publications View
Differential state-dependent Nav1.8 inhibition by suzetrigine, LTGO-33, and A-887826.
Authors: Authors: Jo S, Fujita A, Osorno T, Stewart RG, Vaelli PM, Bean BP.
J Gen Physiol
View full abstract on Pubmed
Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine.
Authors: Authors: Stewart RG, Osorno T, Fujita A, Jo S, Ferraiuolo A, Carlin K, Bean BP.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Response to a Letter to the Editor: An alternative mechanism for slow pacemaking.
Authors: Authors: Bean BP.
J Physiol
View full abstract on Pubmed
State-dependent inhibition of Nav1.8 channels by VX-150 and VX-548.
Authors: Authors: Vaelli P, Fujita A, Jo S, Zhang HB, Osorno T, Ma X, Bean BP.
Mol Pharmacol
View full abstract on Pubmed
Mechanisms of pacemaking in mammalian neurons.
Authors: Authors: Bean BP.
J Physiol
View full abstract on Pubmed
Downregulation of the silent potassium channel Kv8.1 increases motor neuron vulnerability in amyotrophic lateral sclerosis.
Authors:
Brain Commun
View full abstract on Pubmed
Cannabidiol inhibits Nav channels through two distinct binding sites.
Authors: Authors: Huang J, Fan X, Jin X, Jo S, Zhang HB, Fujita A, Bean BP, Yan N.
Nat Commun
View full abstract on Pubmed
Scalable generation of sensory neurons from human pluripotent stem cells.
Authors: Authors: Deng T, Jovanovic VM, Tristan CA, Weber C, Chu PH, Inman J, Ryu S, Jethmalani Y, Ferreira de Sousa J, Ormanoglu P, Twumasi P, Sen C, Shim J, Jayakar S, Bear Zhang HX, Jo S, Yu W, Voss TC, Simeonov A, Bean BP, Woolf CJ, Singeç I.
Stem Cell Reports
View full abstract on Pubmed
Use-dependent relief of inhibition of Nav1.8 channels by A-887826.
Authors: Authors: Jo S, Zhang HB, Bean BP.
Mol Pharmacol
View full abstract on Pubmed
Cannabidiol activates neuronal Kv7 channels.
Authors: Authors: Zhang HB, Heckman L, Niday Z, Jo S, Fujita A, Shim J, Pandey R, Al Jandal H, Jayakar S, Barrett LB, Smith J, Woolf CJ, Bean BP.
Elife
View full abstract on Pubmed